Inogen (INGN) Other Non-Current Assets (2013 - 2026)
Inogen's (INGN) quarterly Other Non-Current Assets came in at $6.9 million in Q2 2026, up 2.86% year-over-year from $6.7 million in Q2 2025, and up 6.89% quarter-over-quarter from $6.5 million in Q1 2026.
Analysis
Inogen (INGN) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Other Non-Current Assets for 14 consecutive years, with $6.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 2.86% year-over-year to $6.9 million in Q2 2026; TTM through Jun 2026 was $6.9 million, a 2.86% increase from a year earlier, with the FY2025 full-year figure at $6.0 million, down 25.73% from the prior year.
- Other Non-Current Assets was $6.9 million for Q2 2026 at Inogen, up from $6.5 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $8.1 million in Q4 2024 and troughed at $2.1 million in Q2 2022.
- A 5-year average of $4.5 million and a median of $3.8 million in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets slumped 36.61% in 2022 and jumped 111.27% in 2024, its largest moves.
- Over 5 years, Other Non-Current Assets stood at $2.4 million in 2022, then surged by 56.44% to $3.8 million in 2023, then jumped by 111.27% to $8.1 million in 2024, then decreased by 25.73% to $6.0 million in 2025, then gained by 14.95% to $6.9 million in 2026.
- The last three Other Non-Current Assets figures came in at $6.9 million (Q2 2026), $6.5 million (Q1 2026), and $6.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | 6.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.90 Mn |
| Mar 31, 2026 | 6.45 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 6.02 Mn |
| Jun 30, 2025 | 6.71 Mn |
| Mar 31, 2025 | 7.02 Mn |
| Dec 31, 2024 | 8.08 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 3.81 Mn |
| Mar 31, 2024 | 3.82 Mn |
| Dec 31, 2023 | 3.83 Mn |
| Sep 30, 2023 | 3.78 Mn |
| Jun 30, 2023 | 2.78 Mn |
| Mar 31, 2023 | 2.59 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 2.32 Mn |
| Jun 30, 2022 | 2.07 Mn |
| Mar 31, 2022 | 2.15 Mn |
| Dec 31, 2021 | 3.36 Mn |
| Sep 30, 2021 | 3.32 Mn |